[PDF] Top 20 Hospitalized cardiovascular events in patients with diabetic macular edema
Has 10000 "Hospitalized cardiovascular events in patients with diabetic macular edema" found on our website. Below are the top 20 most common "Hospitalized cardiovascular events in patients with diabetic macular edema".
Hospitalized cardiovascular events in patients with diabetic macular edema
... CVA events were identified using inpatient claims as defined by "Place of Service" field codes = 5 or 6 for "Inpatient hospital" and “ Healthcare Cost Category” field code = ...Outcome ... See full document
7
Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
... 345 patients affected by diabetic macular edema to compare the effects secondary to laser treatment, ranibizumab injections, or combination of the two ...All patients were randomized to ... See full document
6
Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study
... in patients with DME associated with DMI, there is a concern that decreases in VEGF levels could lead to a decrease in capillary density as well as FAZ increase with consequent loss of ...of macular ... See full document
7
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
... Methods: A Markov model was adapted to compare the use of ranibizumab 0.5 mg (pro re nata-PRN and treat and extend-T&E) to aflibercept 2 mg (every 8 weeks after five initial doses) in DME. Patients ... See full document
9
An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
... and is currently approved for the treatment of age-related macular degeneration but not for DME. A Phase II/III trial demonstrated that compared with sham treatment, admin- istration of intravitreal pegaptanib ... See full document
7
Psychometric validation of the visual function questionnaire-25 in patients with diabetic macular edema
... has been developed to be appropriate to use across a range of visual disorders and to measure their effects. This is an advantage over other measures which are more specific such as the VF-14 [4] which was devel- oped to ... See full document
11
Remote Ischemic Preconditioning and Diabetic Macular Edema
... on diabetic macular edema in patients referring to Yazd Diabetes Research ...Forty patients were selected and put into two groups ... See full document
6
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
... months. Patients receiving ranibizumab consistently achieved superior gains in vision compared with those randomized to sham, a finding that applied to all subtypes of diabetic patients, and to those ... See full document
11
Cross Validation of the Turkish Version of the 28 Item Impact of Vision Impairment Profile Test
... in patients with low vision with reliable tests. Diabetic macular edema is a vision threatening complication of diabetes mel- litus (DM) in working-age adults [22] ...[24]. Diabetic ... See full document
9
Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microa- neurysm photocoagulation on diabetic macular edema
... the patients with MAs at the posterior pole underwent STTA combined with MAPC immediately or within 1 month after the STTA ...with macular edema with CMT ... See full document
6
Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries
... recruited patients who received 20 mg IVTA for treating various retinal and optic nerve diseases over the past 5 ...168 patients. The main indication for high-dose IVTA were diabetic macular ... See full document
9
Vitrectomy for center-involved diabetic macular edema
... all patients and varied according to retinal pathology and era during which surgery was ...All patients underwent vitrec- tomy with removal of the posterior hyaloid and performance of panretinal ... See full document
8
COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOWNLOAD/VIEW
... in patients who had never previously underwent treatment with laser photocoagulation, intravitreal injections, or ...central macular thickness more than 250 µm, as measured by spectral domain optical ... See full document
9
The clinical utility of aflibercept for diabetic macular edema
... center-involving diabetic macular edema (DME) has improved because of the proven efficacy of drugs that inhibit the effects of vascular endothelial growth factor ...for diabetic retinopathy in ... See full document
10
The role of aflibercept in the management of diabetic macular edema
... Previous treatment strategies for DME such as steroid and laser photocoagulation have been shown to effectively pre- serve the vision. The effectiveness of anti-VEGF therapy to improve the vision in patients with ... See full document
8
An Analytical study Correlating the Significance of Serum Lipids in the Development of Clinically Significant Macular Edema in Patients with Diabetic Retinopathy
... records. Diabetic Macular Edema forms the leading cause of blindness among the patients with diabetic ...of diabetic retinopathy and the various risk factors, including level of ... See full document
123
Primary treatment of diabetic macular edema
... when edema affects the central retina or macula (diabetic macular edema, or ...DME). Macular edema is reversible in the early stages but chronic edema may lead to ... See full document
8
Update on corticosteroids for diabetic macular edema
... in patients being considered for cataract sur- gery in the near ...in patients who wish to reduce the number of required injections and in pregnant patients who require treatment of the DME before ... See full document
8
Current status and future trends of clinical diagnoses via image-based deep learning
... AMD is a leading cause of irreversible visual loss in the aging population; the meta-analysis conducted by Wong et al [32] suggested that AMD, was responsible for 8.7% of all global blindness. Fortunately, the ... See full document
10
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
... adverse events was collected for all patients after the first administration of study drug on day - 1 and continuing through day 90 (or early ...adverse events were assessed according to their ... See full document
11
Related subjects